REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Y.S.P. Southeast Asia Holding Berhad (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Y.S.P. Southeast Asia Holding Berhad Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Y.S.P. Southeast Asia Holding Berhad produces and trades pharmaceuticals and healthcare products. The products comprise of tablets, capsules, suppositories, ointments, creams, powders and syrups. The production plants are situated on 3 acres of land, which is located at Bandar Baru Bangi, Kajang. The products are exported to Singapore, Vietnam and Philippines. The company was incorporated in 2001 and is based in Kuala Lumpur.

Headquarters
Level 22, Menara Lgb, No. 1, Jalan Wan Kadir, Taman Tun Dr. Ismail
Kuala Lumpur; Federal Territories; Postal Code: 60000

Contact Details: Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.

Website: http://www.yspsah.com

Basic Information
Total Employees:
Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.
Outstanding Shares:
Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.
Financial Auditors:
Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.
Incorporation Date:
October 07, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
37.09%
Purchase this report to view the information.
11.02%
Purchase this report to view the information.
1.69%
Purchase this report to view the information.
1.59%
Purchase this report to view the information.
1.03%
Subsidiaries
Y.S.P. Cambodia Pte. Ltd. (Cambodia)
100%
Y.S.P. Sah Investment Pte Ltd (Singapore)
100%
Yung Shin Pharmaceutical (Singapore) Pte. Ltd. (Singapore)
100%
Company Performance
Financial values in the chart are available after Y.S.P. Southeast Asia Holding Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
6.21%▲
Total operating revenue
6.34%▲
Operating profit (EBIT)
7.11%▲
EBITDA
6.39%▲
Net Profit (Loss) for the Period
8.77%▲
Total assets
9.85%▲
Total equity
6.15%▲
Operating Profit Margin (ROS)
0.11%▲
Net Profit Margin
0.26%▲
Return on Equity (ROE)
0.23%▲
Debt to Equity Ratio
4.67%▲
Quick Ratio
-0.06%▼
Cash Ratio
-0.82%▼

Similar companies

Pharmaniaga Berhad
 
Vance Bioenergy Sdn. Bhd.
Pharmaniaga Lifescience Sdn. Bhd.
 
Igb Berhad
Abbott Laboratories (Malaysia) Sdn. Bhd.
 
Apex Healthcare Bhd
Duopharma (M) Sendirian Berhad
 
Y.S.P. Industries (M) Sdn. Bhd.
Kotra Industries Berhad
 
Hovid Berhad
Xepa-Soul Pattinson (Malaysia) Sdn Bhd
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo